Daewoong Pharma Capital Reinvestment Ratio
Daewoong Pharma capital reinvestment ratio. Daewoong Pharma (069620) has a Capital Reinvestment Ratio of 1.26x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩57.53 Billion) in capital expenditures (₩72.21 Billion). See how much free cash does Daewoong Pharma generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Daewoong Pharma (2007–2024)
Capital reinvestment ratio of Daewoong Pharma from 2007 to 2024. This chart tracks Daewoong Pharma's Capital Reinvestment Ratio across 16 annual periods. See Daewoong Pharma (069620) flexibility index to measure the company's free cash flow as a share of total liabilities.
Daewoong Pharma Capital Reinvestment Ratio by Year (2007–2024)
Daewoong Pharma capital reinvestment ratio by year from 2007 to 2024. For the full cash flow conversion analysis, see Daewoong Pharma operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 4.45x | ₩51.49 Billion | ₩229.00 Billion | ▲ +396.8% |
| 2023 | 0.90x | ₩132.57 Billion | ₩118.67 Billion | ▲ +62.2% |
| 2022 | 0.55x | ₩118.21 Billion | ₩65.23 Billion | ▼ -24.1% |
| 2021 | 0.73x | ₩39.99 Billion | ₩29.09 Billion | ▲ +177.3% |
| 2020 | 0.26x | ₩100.98 Billion | ₩26.49 Billion | ▼ -32.3% |
| 2019 | 0.39x | ₩57.60 Billion | ₩22.31 Billion | ▼ -67.7% |
| 2018 | 1.20x | ₩47.50 Billion | ₩56.99 Billion | ▲ +80.4% |
| 2017 | 0.67x | ₩103.94 Billion | ₩69.12 Billion | ▼ -93.7% |
| 2016 | 10.62x | ₩15.38 Billion | ₩163.25 Billion | ▲ +300.5% |
| 2015 | 2.65x | ₩35.89 Billion | ₩95.13 Billion | ▲ +49.5% |
| 2014 | 1.77x | ₩25.95 Billion | ₩46.00 Billion | ▲ +404.3% |
| 2013 | 0.35x | ₩54.16 Billion | ₩19.04 Billion | ▼ -33.4% |
| 2012 | 0.53x | ₩45.02 Billion | ₩23.77 Billion | ▲ +1.7% |
| 2011 | 0.52x | ₩78.82 Billion | ₩40.92 Billion | ▼ -54.0% |
| 2008 | 1.13x | ₩31.33 Billion | ₩35.35 Billion | ▼ -18.8% |
| 2007 | 1.39x | ₩25.81 Billion | ₩35.89 Billion | — |